module 6 cholinergic agonists Flashcards
cholinergic receptors
M1: autonomic ganglia, CNS M2: cardiac muscle M3: smooth mucsle, glandular tissues M4: CNS M5: CNS -> MUSCARINIC
Nm: skeletal muscle at NMJ
Nn: autonomic ganglia, adrenal medulla, CNS
-> NICOTINIC
ACh effects on muscarinic receptors: vasculature
release of NO and vasodilation
ACh effects on muscarinic receptors: eye iris (pupil muscle)
contraction and miosis
ACh effects on muscarinic receptors: ciliary muscle
thin and watery secretion
ACh effects on muscarinic receptors: salivary and lacrimal glands
release of NO and vasodilation
ACh effects on muscarinic receptors: bronchi
constriction
inc. secretions
ACh effects on muscarinic receptors: heart
dec. HR
dec. conduction rate
AV block at high doses
dec. contractility
ACh effects on muscarinic receptors: GI tract
inc. tone
inc. secretions
relaxation of sphincters
ACh effects on muscarinic receptors: Urinary bladder
contraction of detrusor muscle
relaxation of sphincter
ACh effects on muscarinic receptors: sweat glands
diaphoresis
ACh effects on muscarinic receptors: reproductive tract; male
erection
AChE inhibitors
inc. concentration of ACh in synapse
- inc. transmission at Nm junction
- inc. PSNS tone
- inc. central cholinergic activity
AChE inhibitor and glaucoma
inc. outflow of aqueous humor
AChE inhibitor and abd. distention
inc. smooth muscle motility
AChE inhibitor adverse effect
inc. ACh
- N/V
- diarrhea
- anorexia
- flatulence
- abd. cramping
muscarinic agonists
dx asthma
miosis and dec. intraocular pressure
GI and GU motility inc.
nicotinic agonists
succinylcholine
resistant to AChE
induction of paralysis by means of depolarizing blockade
muscarinic antagonists
allow sympathetic responses to dominate
muscarinic antagonists adverse effects
anti-cholinergic
- blurred vision
- dry mouth
- ileus
- urinary retention
- flushing
- agitation
- tachycardia
Nicotinic Antagonists
prevent andogenous ACh binding to nicotinic receptors and subsequent muscle cell depolarization
paralysis
AChE inhibitors use
inc. levels of ACh
myasthenia gravis
glaucoma
alzheimers
Nicotine agonists and antagonists use
neuromuscular paralyzing agents
muscarinic agonist use
dx asthma
GI/GU motility
dec. intraocular pressure
muscarinic antagonist use
motion sickness bronchodilator overactive bladder bradycardia mydriasis